Cancer BiologybioRxivPreprint
Toward pharmacologic therapy for glioblastoma: Characterization of the very long-chain acyl-CoA synthetase 3 (ACSVL3) inhibitor Grassofermata
Emily M. Clay, Xiaohai Shi, Elizabeth Anne Kolar…·Paul A. Watkins
This study identifies CB5 (grassofermata) as a potential inhibitor of ACSVL3, showing reduced glioma cell growth and malignancy in vitro and in vivo.
DOI 10.64898/2026.07.07.736493